BIOMAT Database Logo BIOMAT Database Logo

[Fosfomycin in the treatment of chronic bronchopneumopathy]. 1978

P Viola, and R A Goatley

UI MeSH Term Description Entries
D001982 Bronchial Diseases Diseases involving the BRONCHI. Bronchial Disease,Disease, Bronchial,Diseases, Bronchial
D001996 Bronchopneumonia Inflammation of the lung parenchyma that is associated with BRONCHITIS, usually involving lobular areas from TERMINAL BRONCHIOLES to the PULMONARY ALVEOLI. The affected areas become filled with exudate that forms consolidated patches. Bronchial Pneumonia,Bronchial Pneumonias,Bronchopneumonias,Pneumonia, Bronchial,Pneumonias, Bronchial
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005578 Fosfomycin An antibiotic produced by Streptomyces fradiae. Phosphonomycin,Fosfomycin Trometamol Salt,Fosfomycin Tromethamine,Monuril,Phosphomycin,Tromethamine, Fosfomycin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

P Viola, and R A Goatley
[Guacetisal in the treatment of acute and chronic bronchopneumopathy].
February 1981, Minerva medica,
P Viola, and R A Goatley
[Progesterone treatment of the obstructive chronic bronchopneumopathy syndrome].
January 1978, Broncho-pneumologie,
P Viola, and R A Goatley
[Role of almitrine in the treatment of chronic obstructive bronchopneumopathy].
May 1987, Revue medicale de Liege,
P Viola, and R A Goatley
[Iatrogenic complications in the treatment of respiratory insufficiency in chronic bronchopneumopathy].
January 1970, Il Friuli medico,
P Viola, and R A Goatley
[Chronic obstructive bronchopneumopathy].
April 1993, Revue medicale de Bruxelles,
P Viola, and R A Goatley
[Electrocardiographic changes in chronic bronchopneumopathy].
January 1969, Godisen zbornik na Medicinskiot fakultet vo Skopje,
P Viola, and R A Goatley
[Letosteine in chronic obstructive bronchopneumopathy].
April 1983, La Clinica terapeutica,
P Viola, and R A Goatley
[Chronic bronchopneumopathy in Klinefelter's syndrome].
November 1977, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
P Viola, and R A Goatley
[Nutrition in chronic obstructive bronchopneumopathy].
November 1991, Schweizerische medizinische Wochenschrift,
P Viola, and R A Goatley
Fosfomycin in treatment of chronic urinary tract infection.
January 1975, Chemotherapy,
Copied contents to your clipboard!